Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Capital Leases (2016 - 2017)

Historic Capital Leases for Neurocrine Biosciences (NBIX) over the last 8 years, with Q1 2017 value amounting to $544000.0.

  • Neurocrine Biosciences' Capital Leases fell 3275.65% to $544000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $544000.0, marking a year-over-year decrease of 3275.65%. This contributed to the annual value of $617000.0 for FY2016, which is 6032.15% down from last year.
  • As of Q1 2017, Neurocrine Biosciences' Capital Leases stood at $544000.0, which was down 3275.65% from $617000.0 recorded in Q4 2016.
  • Neurocrine Biosciences' 5-year Capital Leases high stood at $3.0 million for Q1 2013, and its period low was $544000.0 during Q1 2017.
  • Moreover, its 5-year median value for Capital Leases was $2.1 million (2015), whereas its average is $1.8 million.
  • Per our database at Business Quant, Neurocrine Biosciences' Capital Leases soared by 3262.51% in 2013 and then crashed by 6121.76% in 2016.
  • Over the past 5 years, Neurocrine Biosciences' Capital Leases (Quarter) stood at $2.7 million in 2013, then fell by 17.5% to $2.2 million in 2014, then decreased by 29.67% to $1.6 million in 2015, then tumbled by 60.32% to $617000.0 in 2016, then dropped by 11.83% to $544000.0 in 2017.
  • Its Capital Leases stands at $544000.0 for Q1 2017, versus $617000.0 for Q4 2016 and $649000.0 for Q3 2016.